ArticleMolecular therapy. Nucleic acids2022

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways.

Guoshu Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.